A5080296675- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urinary and Genital Oncology Studies
- Renal cell carcinoma treatment
- Urological Disorders and Treatments
- Multiple and Secondary Primary Cancers
- Radiomics and Machine Learning in Medical Imaging
- Urologic and reproductive health conditions
- Renal and Vascular Pathologies
- Urinary Bladder and Prostate Research
- Renal and related cancers
- Cancer, Lipids, and Metabolism
- Hormonal and reproductive studies
- MRI in cancer diagnosis
- Cancer Genomics and Diagnostics
- Cancer Diagnosis and Treatment
- Sexual function and dysfunction studies
- Pelvic floor disorders treatments
- Genital Health and Disease
- Pediatric Urology and Nephrology Studies
- Cardiac, Anesthesia and Surgical Outcomes
- Urinary Tract Infections Management
- Colorectal Cancer Surgical Treatments
- Testicular diseases and treatments
University of Messina
2024-2025
Istituto Ortopedico Gaetano Pini
2024-2025
European Institute of Oncology
2017-2024
Istituti di Ricovero e Cura a Carattere Scientifico
2017-2024
Ripamonti
2017-2023
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
2023
University of Milan
2022
University of Naples Federico II
2022
Ospedale Maggiore
2022
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2022
Abstract BACKGROUND The aim of this study was to map the nodal metastases distribution in patients with high‐risk prostate cancer (PCa) treated extended pelvic lymph node dissection (ePLND) and retroperitoneal (rLND) at time radical prostatectomy (RP). MATERIALS AND METHODS This prospective mapping included 19 PCa (sharing least two out three following parameters: PSA >20 ng/ml, cT3, biopsy Gleason score ≥8). All were RP, ePLND (removal obturator, hypogastric, external iliac, presacral,...
To test whether the number of lymph nodes removed affects cancer-specific survival (CSS) or metastatic progression-free (MPFS) in different renal cell carcinoma (RCC) scenarios.We used Cox regression analyses to analyse effect on CSS and MPFS 1983 patients with RCC treated nephrectomy. adjust for possible clinical surgical selection bias, were further adjusted positive nodes, presence metastases, age, performance status, T stage, tumour size grade.The prevalence node invasion was 6.1%. The...
Purpose: To test the impact of surgeon experience on urinary continence (UC) recovery after robot-assisted radical prostatectomy (RARP). Materials and Methods: The study included 1477 consecutive patients treated with RARP by four surgeons between 2006 2014. UC was defined as being completely dry over a 24-hour period at follow-up. Surgeon coded total number performed before patient's operation. Multivariable analysis tested association recovery. Covariates consisted patient age, Charlson...
Several biochemical and clinical markers have been proposed for selecting patients active surveillance (AS). However, some of these are expensive not easily accessible. Moreover, currently about 30% on AS harbor aggressive disease. Hence, there is an urgent need other tools to accurately identify with low-risk prostate cancer (PCa).We retrospectively reviewed the medical records 260 who underwent radical prostatectomy were eligible according following criteria: stage T2a or less,...
• To identify clinical and pathological variables that may help clinicians in predicting, preventing managing lymphorrhoea clinically significant lymphocoeles (CSL), which are reported complications after pelvic lymphadenectomy (PLND) retropubic radical prostatectomy (RRP).• We prospectively analysed 552 consecutive men with prostate cancer who underwent RRP PLND (2006-2008). All patients had detailed data recorded an electronic database. Drains were removed when the amount of lymph was < 20...
To identify preoperatively patients who might benefit from lymph node dissection (LND).We assessed invasion (LNI) at final pathology and (LN) progression during the follow-up for 1983 with RCC, treated either partial or radical nephrectomy. LN was defined as onset of a new clinically detected lymphadenopathy (>10 mm) in retroperitoneal lymphatic area. Logistic regression analyses were used to assess effect each potential clinical predictor (age, body mass index, tumour side, symptoms,...
Head-to-head comparisons between ileal conduit (IC) and orthotopic neobladder (ONB) in terms of peri- postoperative outcomes complications, the specific setting robot-assisted radical cystectomy (RARC), are not available.To address impact type urinary diversion (UD, IC vs ONB) on RARC morbidity, as well operative time (OT), length stay (LOS), readmissions.Urothelial bladder cancer patients treated with at nine high-volume European institutions 2008 2020 were identified.RARC either or...
Socioeconomic status and geographical location contribute to disparities in localized prostate cancer (PCa) treatment. We examined the impact of area deprivation index (ADI) on initial treatment type for PCa a North-American cohort. performed retrospective analysis patients diagnosed with PCa, treated within Henry Ford Health (HFH), between 1995 2022, available ADI-data. ADI was assigned based residential census block group, ranked as national percentile. Patients were categorized into three...